Technology

Cryolife

$25.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.20%) Today
$0.00 (0.00%) As of 11:01 PM UTC after-hours

Why Robinhood?

You can buy or sell Cryolife and other stocks, options, and ETFs commission-free!

About CRY

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices. It operates through the following segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of BioGlue; JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot and PhotoFix. The Preservation Services segment focuses on external services revenues from the preservation of cardiac and vascular tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA. The listed name for CRY is CryoLife, Inc.

CEO
James Patrick Mackin
Employees
1,200
Headquarters
Kennesaw, Georgia
Founded
1984
Market Cap
966.80M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
190.69K
High Today
$25.62
Low Today
$24.81
Open Price
$25.17
Volume
424.49K
52 Week High
$31.77
52 Week Low
$12.63

Collections

CRY Earnings

-$0.14
-$0.05
$0.04
$0.13
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 11, After Hours

You May Also Like

DFHT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure